These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9580660

  • 1. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms.
    Matsumura Y, Nishigori C, Yagi T, Imamura S, Takebe H.
    Hum Mol Genet; 1998 Jun; 7(6):969-74. PubMed ID: 9580660
    [Abstract] [Full Text] [Related]

  • 2. Xeroderma pigmentosum group F protein binds to Eg5 and is required for proper mitosis: implications for XP-F and XFE.
    Tan LJ, Saijo M, Kuraoka I, Narita T, Takahata C, Iwai S, Tanaka K.
    Genes Cells; 2012 Mar; 17(3):173-85. PubMed ID: 22353549
    [Abstract] [Full Text] [Related]

  • 3. Complete restoration of normal DNA repair characteristics in group F xeroderma pigmentosum cells by over-expression of transfected XPF cDNA.
    Yagi T, Matsumura Y, Sato M, Nishigori C, Mori T, Sijbers AM, Takebe H.
    Carcinogenesis; 1998 Jan; 19(1):55-60. PubMed ID: 9472693
    [Abstract] [Full Text] [Related]

  • 4. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
    Ahmad A, Enzlin JH, Bhagwat NR, Wijgers N, Raams A, Appledoorn E, Theil AF, J Hoeijmakers JH, Vermeulen W, J Jaspers NG, Schärer OD, Niedernhofer LJ.
    PLoS Genet; 2010 Mar 05; 6(3):e1000871. PubMed ID: 20221251
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of group F xeroderma pigmentosum cells to UV and mitomycin C relative to levels of XPF and ERCC1 overexpression.
    Yagi T, Katsuya A, Koyano A, Takebe H.
    Mutagenesis; 1998 Nov 05; 13(6):595-9. PubMed ID: 9862190
    [Abstract] [Full Text] [Related]

  • 6. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease.
    Sijbers AM, de Laat WL, Ariza RR, Biggerstaff M, Wei YF, Moggs JG, Carter KC, Shell BK, Evans E, de Jong MC, Rademakers S, de Rooij J, Jaspers NG, Hoeijmakers JH, Wood RD.
    Cell; 1996 Sep 06; 86(5):811-22. PubMed ID: 8797827
    [Abstract] [Full Text] [Related]

  • 7. Deep intronic founder mutations identified in the ERCC4/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum.
    Senju C, Nakazawa Y, Oso T, Shimada M, Kato K, Matsuse M, Tsujimoto M, Masaki T, Miyazaki Y, Fukushima S, Tateishi S, Utani A, Murota H, Tanaka K, Mitsutake N, Moriwaki S, Nishigori C, Ogi T.
    Proc Natl Acad Sci U S A; 2023 Jul 04; 120(27):e2217423120. PubMed ID: 37364129
    [Abstract] [Full Text] [Related]

  • 8. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease.
    Sijbers AM, van Voorst Vader PC, Snoek JW, Raams A, Jaspers NG, Kleijer WJ.
    J Invest Dermatol; 1998 May 04; 110(5):832-6. PubMed ID: 9579555
    [Abstract] [Full Text] [Related]

  • 9. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C, Fujisawa H, Uyeno K, Kawaguchi T, Takebe H.
    Photodermatol Photoimmunol Photomed; 1991 Aug 04; 8(4):146-50. PubMed ID: 1814424
    [Abstract] [Full Text] [Related]

  • 10. Mapping of interaction domains between human repair proteins ERCC1 and XPF.
    de Laat WL, Sijbers AM, Odijk H, Jaspers NG, Hoeijmakers JH.
    Nucleic Acids Res; 1998 Sep 15; 26(18):4146-52. PubMed ID: 9722633
    [Abstract] [Full Text] [Related]

  • 11. Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.
    Tofuku Y, Nobeyama Y, Kamide R, Moriwaki S, Nakagawa H.
    J Dermatol; 2015 Sep 15; 42(9):897-9. PubMed ID: 26010807
    [Abstract] [Full Text] [Related]

  • 12. The age-related expression decline of ERCC1 and XPF for forensic age estimation: A preliminary study.
    Deng XD, Gao Q, Zhang W, Zhang B, Ma Y, Zhang LX, Muer C, Xie Y, Liu Y.
    J Forensic Leg Med; 2017 Jul 15; 49():15-19. PubMed ID: 28486142
    [Abstract] [Full Text] [Related]

  • 13. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH, Arlett CF, Hartley JA, Parris CN.
    Exp Cell Res; 2007 Feb 15; 313(4):753-60. PubMed ID: 17188678
    [Abstract] [Full Text] [Related]

  • 14. True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product.
    Rapić-Otrin V, Navazza V, Nardo T, Botta E, McLenigan M, Bisi DC, Levine AS, Stefanini M.
    Hum Mol Genet; 2003 Jul 01; 12(13):1507-22. PubMed ID: 12812979
    [Abstract] [Full Text] [Related]

  • 15. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.
    Kashiyama K, Nakazawa Y, Pilz DT, Guo C, Shimada M, Sasaki K, Fawcett H, Wing JF, Lewin SO, Carr L, Li TS, Yoshiura K, Utani A, Hirano A, Yamashita S, Greenblatt D, Nardo T, Stefanini M, McGibbon D, Sarkany R, Fassihi H, Takahashi Y, Nagayama Y, Mitsutake N, Lehmann AR, Ogi T.
    Am J Hum Genet; 2013 May 02; 92(5):807-19. PubMed ID: 23623389
    [Abstract] [Full Text] [Related]

  • 16. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
    Takayama K, Salazar EP, Lehmann A, Stefanini M, Thompson LH, Weber CA.
    Cancer Res; 1995 Dec 01; 55(23):5656-63. PubMed ID: 7585650
    [Abstract] [Full Text] [Related]

  • 17. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A, Hofmann L, Gratchev A, Laspe P, Schubert S, Schürer A, Ohlenbusch A, Tzvetkov M, Hallermann C, Reichrath J, Schön MP, Emmert S.
    Exp Dermatol; 2013 Jan 01; 22(1):24-9. PubMed ID: 23173980
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
    Kobayashi T, Kuraoka I, Saijo M, Nakatsu Y, Tanaka A, Someda Y, Fukuro S, Tanaka K.
    Hum Mutat; 1997 Jan 01; 9(4):322-31. PubMed ID: 9101292
    [Abstract] [Full Text] [Related]

  • 19. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
    Sabatella M, Theil AF, Ribeiro-Silva C, Slyskova J, Thijssen K, Voskamp C, Lans H, Vermeulen W.
    Nucleic Acids Res; 2018 Oct 12; 46(18):9563-9577. PubMed ID: 30165384
    [Abstract] [Full Text] [Related]

  • 20. Repair of damaged DNA by extracts from a xeroderma pigmentosum complementation group A revertant and expression of a protein absent in its parental cell line.
    Jones CJ, Cleaver JE, Wood RD.
    Nucleic Acids Res; 1992 Mar 11; 20(5):991-5. PubMed ID: 1549511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.